Skip to content
AIインテリジェンスMay 15, 2026AIインテリジェンス
記事

TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.

The company is developing novel therapies to overcome resistance to cancer immunotherapy.

Data Cube AI 編集部出典: PR Newswire
01

ソース要約

TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.